Altimmune Inc (ALT)
8.265
+0.08
(+1.04%)
USD |
NASDAQ |
Dec 20, 16:00
8.30
+0.04
(+0.42%)
After-Hours: 20:00
Altimmune Market Cap: 587.84M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
NovaBay Pharmaceuticals Inc | 2.589M |
Palatin Technologies Inc | 18.92M |
iBio Inc | 22.69M |
Theriva Biologics Inc | 3.172M |
Oragenics Inc | 4.338M |
Market Cap Related Metrics
PS Ratio | 10780.69 |
PEG Ratio | -2.702 |
Price to Book Value | 4.407 |
Price | 8.265 |
Earnings Yield | -19.00% |